Murine miR-322 promotes Th17 cell differentiation through its targeting of the transcription factor NF-kB subunit p50 (88), which is interesting because of the prominent role of Th17 and IL-17 as disease drivers in SS (89). Here, NFKB1 is linked to synovial sarcoma.